argenx SE (ARGX) Financials
ARGX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 5.0 billion | 491.9 million |
2023-09-30 | ? | ? |
2023-06-30 | 3.5 billion | 365.1 million |
2023-03-31 | ? | ? |
ARGX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -124.9 million | ? |
2023-09-30 | ? | ? |
2023-06-30 | -281.6 million | ? |
2023-03-31 | ? | ? |
ARGX Net Income
No data available :(
ARGX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 3.5 billion | - | - |
2023-09-30 | 2.0 billion | - | - |
2023-06-30 | 2.2 billion | - | 12.2 million |
2023-03-31 | - | - | - |
ARGX Shares Outstanding
ARGX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 48.0 million | 551.5 million | - | - |
2023-09-30 | - | 203.0 million | 203.2 million | - |
2023-06-30 | 521682 | 212.6 million | 174.9 million | - |
2023-03-31 | - | 180.8 million | 162.6 million | - |
ARGX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 815.5 million | 201.7 million |
2023-09-30 | 349.1 million | 38.1 million |
2023-06-30 | 294.2 million | 26.1 million |
2023-03-31 | 238.9 million | 20.0 million |
ARGX
Price: $388.20
52 week price:
Earnings Per Share: -5.14 USD
P/E Ratio: -95.08
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 205974
Ebitda: -24.6 millionMarket Capitalization: 22.9 billion